APG Asset Management N.V. trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 871,982 shares of the healthcare conglomerate’s stock after selling 6,100 shares during the period. APG Asset Management N.V. owned approximately 0.09% of UnitedHealth Group worth $170,778,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also recently modified their holdings of the company. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group during the 2nd quarter valued at approximately $110,000. Bruderman Asset Management LLC acquired a new position in UnitedHealth Group in the 2nd quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares in the last quarter. BDO Wealth Advisors LLC acquired a new position in UnitedHealth Group in the 2nd quarter valued at approximately $121,000. Finally, Kings Point Capital Management raised its holdings in UnitedHealth Group by 27.9% in the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares in the last quarter. 86.01% of the stock is currently owned by institutional investors.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last quarter, insiders sold 34,630 shares of company stock valued at $7,669,416. 0.89% of the stock is currently owned by corporate insiders.
A number of equities analysts have recently issued reports on UNH shares. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price for the company in a report on Thursday, September 21st. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $210.00 price target on shares of UnitedHealth Group in a report on Tuesday, October 10th. Jefferies Group increased their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Friday, October 13th. Finally, BMO Capital Markets started coverage on UnitedHealth Group in a research report on Monday, October 16th. They issued an “outperform” rating and a $250.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $226.74.
UnitedHealth Group Inc (NYSE:UNH) traded up $1.19 during trading on Thursday, reaching $225.39. The company had a trading volume of 2,543,589 shares, compared to its average volume of 2,960,000. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The company has a market capitalization of $217,920.00, a PE ratio of 25.61, a P/E/G ratio of 1.57 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The company had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. The business’s revenue was up 8.7% on a year-over-year basis. sell-side analysts anticipate that UnitedHealth Group Inc will post 9.99 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.
WARNING: “UnitedHealth Group Inc (NYSE:UNH) Shares Sold by APG Asset Management N.V.” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/11/apg-asset-management-n-v-sells-6100-shares-of-unitedhealth-group-incorporated-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.